Providence Little Co Of Mary Transitional Care Ctr | |
4320 Maricopa Street, Torrance, California 90503 | |
(310) 303-5900 | |
Name | Providence Little Co Of Mary Transitional Care Ctr |
---|---|
Location | 4320 Maricopa Street, Torrance, California |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 115 |
Occupancy Rate | 35.91% |
Medicare ID (CCN) | 056499 |
Legal Business Name | Providence Health System - Southern California |
Ownership Type | Non Profit - Church Related |
NPI Number | 1013931328 |
Organization Name | LITTLE COMPANY OF MARY HOSPITAL |
Doing Business As | LITTLE COMPANY OF MARY PAVILION |
Address | 4320 Maricopa St, Torrance, CA 90503 |
Phone Number | 310-303-7496 |
News Archive
Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
A study of where and how an enzyme cuts DNA may have inadvertently revealed a basic principle of gene regulation, say researchers in Boston Children's Hospital's Program in Cellular and Molecular Medicine (PCMM).
A recent study aimed to determine the efficacy of pronation maneuvers by the ICU physiotherapy team when used on critically ill COVID-19 patients.
Sudha Seshadri, MD, professor of neurology at Boston University School of Medicine, has been awarded three grants this year totaling nearly $20 million from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.
› Verified 3 days ago
NPI Number | 1295771483 |
Organization Name | LITTLE COMPANY OF MARY - SAN PEDRO HOSPITAL |
Doing Business As | LITTLE COMPANY OF MARY SUB ACUTE CARE CENTER |
Address | 3620 Lomita Blvd, Torrance, CA 90505 |
Phone Number | 310-303-7561 |
News Archive
Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
A study of where and how an enzyme cuts DNA may have inadvertently revealed a basic principle of gene regulation, say researchers in Boston Children's Hospital's Program in Cellular and Molecular Medicine (PCMM).
A recent study aimed to determine the efficacy of pronation maneuvers by the ICU physiotherapy team when used on critically ill COVID-19 patients.
Sudha Seshadri, MD, professor of neurology at Boston University School of Medicine, has been awarded three grants this year totaling nearly $20 million from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.
› Verified 3 days ago
NPI Number | 1891718797 |
Organization Name | SAN PEDRO PENINSULA HOSPITAL |
Doing Business As | LITTLE COMPANY OF MARY SUB ACUTE CARE CENTER |
Address | 3620 Lomita Blvd, Torrance, CA 90505 |
Phone Number | 310-303-7561 |
News Archive
Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
A study of where and how an enzyme cuts DNA may have inadvertently revealed a basic principle of gene regulation, say researchers in Boston Children's Hospital's Program in Cellular and Molecular Medicine (PCMM).
A recent study aimed to determine the efficacy of pronation maneuvers by the ICU physiotherapy team when used on critically ill COVID-19 patients.
Sudha Seshadri, MD, professor of neurology at Boston University School of Medicine, has been awarded three grants this year totaling nearly $20 million from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.
› Verified 3 days ago
NPI Number | 1952348518 |
Organization Name | PROVIDENCE HEALTH SYSTEM SOUTHERN CALIFORNIA |
Doing Business As | PROVIDENCE LITTLE COMPANY OF MARY TRANSITIONAL CARE CENTER |
Address | 4320 Maricopa St, Torrance, CA 90503 |
Phone Number | 310-303-7496 |
News Archive
Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
A study of where and how an enzyme cuts DNA may have inadvertently revealed a basic principle of gene regulation, say researchers in Boston Children's Hospital's Program in Cellular and Molecular Medicine (PCMM).
A recent study aimed to determine the efficacy of pronation maneuvers by the ICU physiotherapy team when used on critically ill COVID-19 patients.
Sudha Seshadri, MD, professor of neurology at Boston University School of Medicine, has been awarded three grants this year totaling nearly $20 million from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
A study of where and how an enzyme cuts DNA may have inadvertently revealed a basic principle of gene regulation, say researchers in Boston Children's Hospital's Program in Cellular and Molecular Medicine (PCMM).
A recent study aimed to determine the efficacy of pronation maneuvers by the ICU physiotherapy team when used on critically ill COVID-19 patients.
Sudha Seshadri, MD, professor of neurology at Boston University School of Medicine, has been awarded three grants this year totaling nearly $20 million from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|